In summary, our findings not only unveiled an acetylation-dependent regulation of FGL1 that may be utilized by tumors for immune evasion, but also linked SIRT2 and aspirin to HCC immunotherapy. This evidence concerns the gene SIRT2 and hepatocellular carcinoma.